<?xml version="1.0" encoding="UTF-8"?>
<p id="Par62">Potential anti-coronavirus therapies can be divided into two categories depending on their target: those that act on the human immune system or human cells, and those that interfere with the coronavirus itself (Wu et al. 
 <xref ref-type="bibr" rid="CR119">2020</xref>). The unmet need for pharmacologically potent and safe antivirals ought to be fulfilled by thinking out of the box and indigenous knowledge of medicinal plants may be a masterstroke against deadly infectious diseases such as COVID-19 (Mahapatra et al. 
 <xref ref-type="bibr" rid="CR78">2019</xref>). Vellingiri et al. (
 <xref ref-type="bibr" rid="CR109">2020</xref>) postulated that medicinal plants are potential sources of drugs for the treatment of COVID-19. Ling (
 <xref ref-type="bibr" rid="CR72">2020</xref>) also submitted that traditional plant medicines are a good source of natural compounds for the discovery and development of drugs against SARS-CoV-2. So, the mortality of COVID-19 patients in China was limited by the use of TCM. As the growing COVID-19 global pandemic reformats the classical norms of pharmaceutical and clinical interventions, this review is a poignant reminder that repurposing of current medicinal plants and other natural products to treat COVID-19 should become part of our new vernacular health system.
</p>
